Differences between the European Union and United States of America in Drug Regulatory Affairs Affect Global Patient Safety Standards and Public Health Awareness: The Case of Deferasirox and Other Iron Chelating Drugs

Regulatory policies on drugs have a major impact on patient safety and survival. Some pharmaceutical companies employ all possible methods to achieve maximum sales in relation to the monopoly of their patented drugs, leading sometimes to irregularities and illegal activities. Misinformation on the o...

Descripción completa

Detalles Bibliográficos
Autor principal: Kontoghiorghes, George J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304852/
https://www.ncbi.nlm.nih.gov/pubmed/34357152
http://dx.doi.org/10.3390/medicines8070036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304852/
https://www.ncbi.nlm.nih.gov/pubmed/34357152
http://dx.doi.org/10.3390/medicines8070036

Ejemplares similares